The RUNX1b Isoform Defines Hemogenic Competency in Developing Human Endothelial Cells

Area of Science:

• Developmental Biology
• Hematopoiesis
• Stem Cell Biology

Background:

• RUNX1 is crucial for blood cell development, regulating the transition from endothelial cells to hematopoietic progenitors.
• Previous studies focused on mouse models, leaving the precise role and expression of RUNX1 isoforms in human hematopoiesis unclear.

Purpose of the Study:

• To investigate the dynamic expression patterns of RUNX1b and RUNX1c isoforms during human hematopoiesis.
• To identify the earliest markers of hemogenic potential in human embryonic stem cells.

Main Methods:

• Utilized a human embryonic stem cell line engineered to express fluorescent reporters for RUNX1b (VENUS) and RUNX1c (TOMATO).
• Employed multi-parameter flow cytometry for single-cell analysis and isolation of RUNX1b-expressing cells.

Main Results:

• Demonstrated sequential expression: RUNX1b is expressed early in endothelial cells and during the endothelium-to-hematopoietic transition, while RUNX1c appears later in definitive blood cells.
• Showed that RUNX1b marks endothelial cells with hemogenic potential, with expression levels correlating to hemogenic competency.

Conclusions:

• RUNX1b is the earliest identified marker for hemogenic competency in human blood specification.
• The differential and sequential expression of RUNX1 isoforms provides critical insights into the regulation of human hematopoiesis.